Searchable abstracts of presentations at key conferences in endocrinology

ea0038p192 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Central IL6 signalling and the development of impaired insulin secretion in type2 diabetes

Yiannakas Adonis , McNeilly Alison D , Gallagher Jennifer , Wright Kathryn , McCrimmmon Rory J

Obesity and the metabolic syndrome are chronic inflammatory states that are now understood to be involved in the development type 2 Diabetes. Hypothalamic cytokine signalling is thought to influence neuroendocrine networks critical to the dynamic maintenance of glucose homeostasis. Interleukin 6 (IL6) is a cytokine that displays tissue-specificity and is instrumental in the mounting of the acute phase response, as well as in the subsequent resolving and adaptive phase. IL6 is ...